NP47725a Emicizumab (Indication Specific)
A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)
- Source
- Find a Tender
- Type
- Framework (Supply)
- Duration
- not specified
- Value
- £3M
- Sector
- HEALTH
- Published
- 27 Oct 2025
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
2 buyers
- NHS National Services Scotland NSS Edinburgh
1 supplier
- Roche Products Welwyn Garden City
Description
Supply of Emicizumab (Indication Specific) to NHS Scotland.
Total Quantity or Scope
The Framework Agreement is for the supply of Emicizumab (Indication Specific) to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.
Award Detail
| 1 | Roche Products (Welwyn Garden City)
|
Award Criteria
| PRICE | _ |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Award on basis of price.
Legal Justification
Competition for some of the medicines awarded to the Framework Agreement is absent for technical reasons, in accordance with Regulation 33(1)(b)(ii) of the Public Contracts (Scotland) Regulations 2015.
Other Information
The estimated value referred to in Section II.I.7 and Section V.2.4 covers the twenty(20) month framework duration and the twenty-eight(28) month extension period of the framework agreement (SC Ref:813958)
Reference
- FTS 068412-2025